MTF2 and neoplasm: Mechanistically, immunohistochemical analysis demonstrated that PCIF1 knockout combined with anti‐PD1 treatment not only reduced the proliferation marker Ki67 but also led to a pronounced upregulation of the tumour suppressor MTF2 (Figure 7G–L).